Economic portfolio
TATA INDIA PHARMA & HEALTHCARE FUND
TATA Tata Mutual Fund Jan 2022 — Sep 2026 56 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 10.5 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
56 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
50.7% now, 52.0% in Sep 2025 · highest 76.4%, lowest 49.7%
Companies held
42 now, 37 in Sep 2025 · largest single holding 8.0% of equity
How long new positions last: of the 31 companies this fund started holding between Aug 2022 and Sep 2025, 74% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: no clear lean toward recent winners or losers (score -0.07 over 16 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 24 shared54.9%
- Bandhan BSE Healthcare Index FundBandhan · 31 shared53.9%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 31 shared53.9%
- NIPPON INDIA PHARMA FUNDNippon India · 22 shared52.6%
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 26 shared50.4%
- UTI - Healthcare FundUTI · 23 shared50.4%
- SBI Healthcare Opportunities FundSBI · 19 shared49.3%
- HDFC Pharma and Healthcare FundHDFC · 18 shared48.9%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Torrent Pharmaceuticals Limited+3,068.5% +1.15 L
- 02 PI Industries Limited+168.8% +1.06 L
- 03 Anthem Biosciences Limited+21.0% +78,579
- 04 Aster DM Quality Care Limited+9.9% +32,734
- 05 Max Healthcare Institute Limited+5.6% +31,818
- 06 FDC Limited+2.2% +21,244
- 07 Acutaas Chemicals Limited+22.3% +16,371
- 08 Symbiotec Pharmalab Limited+10.9% +11,039
- 09 Procter & Gamble Health Limited+9.7% +6,602
- 10 Apollo Hospitals Enterprise Limited+6.2% +4,694
Largest reductions
- 01 Fortis Healthcare Limited-32.7% -1.86 L
- 02 Mankind Pharma Limited-75.4% -1.42 L
- 03 Manipal Health Enterprises Limited-50.0% -1.27 L
- 04 GlaxoSmithKline Pharmaceuticals Limited-70.2% -98,061
- 05 Biocon Limited-25.7% -96,665
- 06 Molbio Diagnostics Limited-50.7% -63,839
- 07 Jubilant Pharmova Limited-99.9% -45,000
- 08 Divi's Laboratories Limited-1.2% -1,111
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 8.02% | 121 Cr | 0.07 Cr | by Jan 2022 (56 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 5.95% | 89.75 Cr | 33,086 | Sep 2025 (13 mo) |
| Healthcare Global Enterprises Limited | Healthcare | Small Cap | 5.94% | 89.52 Cr | 0.13 Cr | by Jan 2022 (56 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 5.69% | 85.82 Cr | 92,361 | by Jan 2022 (56 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 4.67% | 70.32 Cr | 0.06 Cr | by Jan 2022 (56 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 4.37% | 65.90 Cr | 80,707 | by Jan 2022 (56 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 4.32% | 65.07 Cr | 0.05 Cr | Jul 2025 (15 mo) |
| Cipla Limited | Healthcare | Large Cap | 4.23% | 63.78 Cr | 0.05 Cr | by Jan 2022 (56 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 3.77% | 56.88 Cr | 0.01 Cr | Aug 2026 (2 mo) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 3.72% | 56.09 Cr | 0.06 Cr | Jul 2025 (15 mo) |
| Lupin Limited | Healthcare | Mid Cap | 3.14% | 47.40 Cr | 0.02 Cr | by Jan 2022 (56 mo+) |
| Bayer Cropscience Limited | Not classified | Small Cap | 2.96% | 44.69 Cr | 0.01 Cr | Nov 2025 (11 mo) |
| Syngene International Limited | Healthcare | Small Cap | 2.86% | 43.10 Cr | 0.12 Cr | Mar 2023 (42 mo) |
| Procter & Gamble Health Limited | Healthcare | Small Cap | 2.75% | 41.50 Cr | 74,596 | Mar 2026 (7 mo) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 2.61% | 39.34 Cr | 0.03 Cr | Aug 2025 (14 mo) |
| PI Industries Limited | Chemicals | Mid Cap | 2.60% | 39.16 Cr | 0.02 Cr | Aug 2026 (2 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 2.58% | 38.89 Cr | 0.05 Cr | Jul 2026 (3 mo) |
| Pfizer Limited | Healthcare | Small Cap | 2.51% | 37.85 Cr | 97,680 | May 2026 (5 mo) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.37% | 35.66 Cr | 69,058 | by Jan 2022 (56 mo+) |
| FDC Limited | Not classified | Small Cap | 2.24% | 33.84 Cr | 0.10 Cr | by Jan 2022 (56 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 1.96% | 29.49 Cr | 0.04 Cr | Nov 2025 (11 mo) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 1.95% | 29.44 Cr | 89,770 | Aug 2026 (2 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 1.77% | 26.67 Cr | 0.01 Cr | Jan 2025 (21 mo) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 1.68% | 25.27 Cr | 0.04 Cr | Aug 2026 (2 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.63% | 24.64 Cr | 68,052 | by Jan 2022 (56 mo+) |
| Natco Pharma Limited | Healthcare | Small Cap | 1.51% | 22.77 Cr | 0.03 Cr | Sep 2026 (1 mo) |
| Sumitomo Chemical India Limited | Chemicals | Small Cap | 1.38% | 20.79 Cr | 0.05 Cr | Mar 2026 (7 mo) |
| Gillette India Limited | Fast Moving Consumer Goods | Small Cap | 1.23% | 18.57 Cr | 26,534 | May 2026 (5 mo) |
| Navin Fluorine International Limited | Chemicals | Small Cap | 1.18% | 17.79 Cr | 21,572 | Sep 2026 (1 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 0.91% | 13.78 Cr | 71,536 | Aug 2026 (2 mo) |
| Prasol Chemicals Limited | Not classified | — | 0.88% | 13.28 Cr | 0.02 Cr | Sep 2026 (1 mo) |
| Symbiotec Pharmalab Limited | Not classified | — | 0.88% | 13.21 Cr | 0.01 Cr | Aug 2026 (2 mo) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 0.77% | 11.58 Cr | 46,256 | May 2023 (40 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 0.77% | 11.55 Cr | 41,697 | Nov 2025 (11 mo) |
| Biocon Limited | Healthcare | Mid Cap | 0.69% | 10.36 Cr | 0.03 Cr | Jul 2026 (3 mo) |
| Dr. Agarwal's Health Care Limited | Not classified | Small Cap | 0.68% | 10.32 Cr | 0.02 Cr | Jan 2025 (21 mo) |
| Manipal Health Enterprises Limited | Not classified | — | 0.60% | 8.98 Cr | 0.01 Cr | Jul 2026 (3 mo) |
| Zim Laboratories Limited | Not classified | Small Cap | 0.58% | 8.71 Cr | 0.06 Cr | Jun 2026 (4 mo) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.58% | 8.67 Cr | 22,809 | Jul 2026 (3 mo) |
| Molbio Diagnostics Limited | Not classified | — | 0.54% | 8.11 Cr | 61,965 | Aug 2026 (2 mo) |
| Gujarat Fluorochemicals Limited | Chemicals | Mid Cap | 0.53% | 8.00 Cr | 18,164 | Sep 2026 (1 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.00% | 0.01 Cr | 49 | Oct 2025 (12 mo) |
Half of its current holdings have been held for 11 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Metropolis Healthcare Limited | Sep 2026 | ▼ Complete exit | -0.03 Cr |
| Natco Pharma Limited | Sep 2026 | ▲ New position | +0.03 Cr |
| Fortis Healthcare Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Global Health Limited | Sep 2026 | ▼ Complete exit | -0.02 Cr |
| Prasol Chemicals Limited | Sep 2026 | ▲ New position | +0.02 Cr |
| HDFC Life Insurance Company Limited | Sep 2026 | ▼ Complete exit | -0.01 Cr |
| Mankind Pharma Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Manipal Health Enterprises Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| PI Industries Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| GlaxoSmithKline Pharmaceuticals Limited | Sep 2026 | ▼ Reducing | -98,061 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -96,665 |
| Anthem Biosciences Limited | Sep 2026 | ▲ Increasing | +78,579 |
| Molbio Diagnostics Limited | Sep 2026 | ▼ Reducing | -63,839 |
| Jubilant Pharmova Limited | Sep 2026 | ▼ Reducing | -45,000 |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +32,734 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +31,818 |
| Navin Fluorine International Limited | Sep 2026 | ▲ New position | +21,572 |
| FDC Limited | Sep 2026 | ▲ Increasing | +21,244 |
| Gujarat Fluorochemicals Limited | Sep 2026 | ▲ New position | +18,164 |
| Acutaas Chemicals Limited | Sep 2026 | ▲ Increasing | +16,371 |
| Symbiotec Pharmalab Limited | Sep 2026 | ▲ Increasing | +11,039 |
| Procter & Gamble Health Limited | Sep 2026 | ▲ Increasing | +6,602 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +4,694 |
| Bayer Cropscience Limited | Sep 2026 | ▲ Increasing | +4,365 |
| Gillette India Limited | Sep 2026 | ▲ Increasing | +3,297 |
| Sanofi Consumer Healthcare India Limited | Sep 2026 | ▲ Increasing | +2,973 |
| Divi's Laboratories Limited | Sep 2026 | ▼ Reducing | -1,111 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +162 |
| Anthem Biosciences Limited | Aug 2026 | ▲ Increasing | +0.04 Cr |
| Aster DM Quality Care Limited | Aug 2026 | ▲ New position | +0.03 Cr |
| Concord Biotech Limited | Aug 2026 | ▼ Complete exit | -0.02 Cr |
| Biocon Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| HDFC Life Insurance Company Limited | Aug 2026 | ▲ New position | +0.01 Cr |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| Molbio Diagnostics Limited | Aug 2026 | ▲ New position | +0.01 Cr |
| Symbiotec Pharmalab Limited | Aug 2026 | ▲ New position | +0.01 Cr |
| Jubilant Pharmova Limited | Aug 2026 | ▼ Reducing | -91,087 |
| Sai Life Sciences Limited | Aug 2026 | ▼ Reducing | -80,414 |
| FDC Limited | Aug 2026 | ▲ Increasing | +76,851 |
| Acutaas Chemicals Limited | Aug 2026 | ▲ New position | +73,399 |
| IPCA Laboratories Limited | Aug 2026 | ▲ New position | +71,536 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +64,676 |
| PI Industries Limited | Aug 2026 | ▲ New position | +63,066 |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +60,000 |
| Global Health Limited | Aug 2026 | ▼ Reducing | -56,126 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▼ Reducing | -41,638 |
| BASF India Limited | Aug 2026 | ▼ Complete exit | -41,008 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -28,173 |
| Procter & Gamble Health Limited | Aug 2026 | ▲ Increasing | +11,597 |
| Sanofi India Limited | Aug 2026 | ▼ Complete exit | -10,635 |
| Neuland Laboratories Limited | Aug 2026 | ▼ Complete exit | -10,134 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +8,820 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ New position | +3,740 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +1,693 |
| Sanofi Consumer Healthcare India Limited | Aug 2026 | ▲ Increasing | +1,473 |
| Gillette India Limited | Aug 2026 | ▼ Reducing | -53 |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +0.03 Cr |
| Manipal Health Enterprises Limited | Jul 2026 | ▲ New position | +0.03 Cr |
| Biocon Limited | Jul 2026 | ▲ New position | +0.02 Cr |
| Max Healthcare Institute Limited | Jul 2026 | ▼ Reducing | -0.02 Cr |
| Sumitomo Chemical India Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Metropolis Healthcare Limited | Jul 2026 | ▼ Reducing | -94,326 |
| FDC Limited | Jul 2026 | ▲ Increasing | +93,880 |
| Healthcare Global Enterprises Limited | Jul 2026 | ▲ Increasing | +63,298 |
| Zim Laboratories Limited | Jul 2026 | ▲ Increasing | +59,564 |
| Sanofi India Limited | Jul 2026 | ▼ Reducing | -54,633 |
| IPCA Laboratories Limited | Jul 2026 | ▼ Complete exit | -50,000 |
| BASF India Limited | Jul 2026 | ▲ New position | +41,008 |
| Rainbow Childrens Medicare Limited | Jul 2026 | ▲ Increasing | +40,743 |
| Sai Life Sciences Limited | Jul 2026 | ▲ Increasing | +39,685 |
| Dr. Agarwal's Health Care Limited | Jul 2026 | ▲ Increasing | +32,554 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▼ Complete exit | -32,086 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -31,614 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▲ Increasing | +30,809 |
| GlaxoSmithKline Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +25,788 |
| Global Health Limited | Jul 2026 | ▼ Reducing | -22,586 |
| Sanofi Consumer Healthcare India Limited | Jul 2026 | ▲ New position | +18,363 |
| Pfizer Limited | Jul 2026 | ▲ Increasing | +15,746 |
| Procter & Gamble Health Limited | Jul 2026 | ▲ Increasing | +15,265 |
| Apollo Hospitals Enterprise Limited | Jul 2026 | ▼ Reducing | -10,152 |
| Divi's Laboratories Limited | Jul 2026 | ▲ Increasing | +8,331 |
| Concord Biotech Limited | Jul 2026 | ▲ Increasing | +7,209 |
| Bayer Cropscience Limited | Jul 2026 | ▲ Increasing | +6,518 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +2,778 |
| Neuland Laboratories Limited | Jul 2026 | ▼ Reducing | -2,414 |
| Anthem Biosciences Limited | Jul 2026 | ▲ New position | +1,400 |
| Zim Laboratories Limited | Jun 2026 | ▲ New position | +0.06 Cr |
| Sumitomo Chemical India Limited | Jun 2026 | ▲ Increasing | +0.02 Cr |
| J.B. Chemicals & Pharmaceuticals Lt | Jun 2026 | ▼ Complete exit | -0.01 Cr |
| Vijaya Diagnostic Centre Limited | Jun 2026 | ▼ Complete exit | -0.01 Cr |
| Concord Biotech Limited | Jun 2026 | ▲ Increasing | +98,329 |
| HDFC Life Insurance Company Limited | Jun 2026 | ▼ Complete exit | -93,446 |
| FDC Limited | Jun 2026 | ▲ Increasing | +79,555 |
| Syngene International Limited | Jun 2026 | ▲ Increasing | +71,317 |
| Jubilant Pharmova Limited | Jun 2026 | ▲ Increasing | +59,833 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▼ Reducing | -57,952 |
| IPCA Laboratories Limited | Jun 2026 | ▲ Increasing | +49,751 |
| Max Healthcare Institute Limited | Jun 2026 | ▲ Increasing | +41,964 |
Changes compare consecutive month-end disclosures for this portfolio only.